hx-630 and Memory-Disorders

hx-630 has been researched along with Memory-Disorders* in 1 studies

Other Studies

1 other study(ies) available for hx-630 and Memory-Disorders

Article	Year
A synthetic retinoid Am80 (tamibarotene) rescues the memory deficit caused by scopolamine in a passive avoidance paradigm. Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:11 Memory deficit in rats treated with scopolamine was rescued by several synthetic retinoids, RAR-ligands (Am80, Am555S, Tp80) and an RXR-ligand (HX630). These results may have implications for the treatment of Alzheimer's disease, age-related dementia, Parkinson's disease, and other neurological disorders. Topics: Animals; Antibodies, Monoclonal; Avoidance Learning; Benzazepines; Benzoates; Dose-Response Relationship, Drug; Male; Memory Disorders; Nootropic Agents; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Wistar; Retinoids; Scopolamine; Tetrahydronaphthalenes; Time Factors; Trimethylsilyl Compounds	2004

Article

Year

A synthetic retinoid Am80 (tamibarotene) rescues the memory deficit caused by scopolamine in a passive avoidance paradigm.

Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:11

Memory deficit in rats treated with scopolamine was rescued by several synthetic retinoids, RAR-ligands (Am80, Am555S, Tp80) and an RXR-ligand (HX630). These results may have implications for the treatment of Alzheimer's disease, age-related dementia, Parkinson's disease, and other neurological disorders.

Topics: Animals; Antibodies, Monoclonal; Avoidance Learning; Benzazepines; Benzoates; Dose-Response Relationship, Drug; Male; Memory Disorders; Nootropic Agents; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Wistar; Retinoids; Scopolamine; Tetrahydronaphthalenes; Time Factors; Trimethylsilyl Compounds

2004